The continuous evolution of neuropharmacology, treatment-resistant neurological anomalies, and alternative psychiatric interventions has challenged traditional clinical perspectives on cognitive regulation. Attention-Deficit/Hyperactivity Disorder (ADHD) has long been managed through standard psychostimulants like methylphenidate and amphetamine derivatives, alongside cognitive behavioral therapy. However, a significant subset of adults experience persistent executive dysfunction, emotional dysregulation, chronic burnout, and compulsive […]